Eli Lilly’s Mounjaro is the only dual drug on the market, targeting GLP-1 and GIP. Doctors say that Mounjaro is also more ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

JUPITER — Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps ...

After a century of false starts, scientists believe they have found a way to make cells burn more energy without the ...

Northwestern University scientists have uncovered a hidden molecular "control switch" inside a protein that helps the body ...

Many people use weight-loss injections to slim down faster, but few consider what happens when they stop. A large ...

Detox supplements may be all the rage, but they can actually be harmful to your body. They may impair nutrient absorption, ...

There are two drugs on the market - semaglutide, marketed under the brand name Wegovy, and tirzepatide, sold as Mounjaro.

Explore innovative Type 2 diabetes drugs that enhance insulin sensitivity and reduce side effects from older treatments.

A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill ...